Company Name: Mesoblast Limited  

Mesoblast Limited is a regenerative medicine company. The company has developed a broad portfolio of late-stage product candidates using its proprietary mesenchymal lineage adult stem cell (MLC)-based platform in several therapeutic areas including:

  • Cardiac diseases
  • Immune-mediated and inflammatory disorders
  • Oncology and hematology conditions
  • Spine orthopedic disorders

Ticker Symbol: MESO (NASDAQ)

Ticker Symbol: MSB (ASX)

Company Website: www.mesoblast.com

Social Media:

Mesoblast LinkedIn

Mesoblast Twitter

Headquarters: Melbourne, Australia